MedTrace Logo

Influenza Vaccination Among the Elderly Individuals

NCT02362919 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2017-09-11

No results posted yet for this study

Summary

The aims of the study are to a) identify individuals with a poor response to influenza vaccination and b) identify factors associated with a poor response to influenza vaccination.

Conditions

Sponsors & Collaborators

  • Clinical Research Center, Hannover, Germany

    collaborator UNKNOWN

  • Hannover Unified Biobank, Hannover, Germany

    collaborator UNKNOWN

  • Hannover Medical School

    collaborator OTHER

  • Helmholtz Centre for Infection Research

    lead OTHER

Principal Investigators

  • Frank Pessler, PD Dr. · Twincore Centre for Experimental and Clinical Infection Research, Hannover, Germany

Eligibility

Min Age
65 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-02-28
Primary Completion
2016-05-31
Completion
2016-05-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02362919 on ClinicalTrials.gov